• 102
  • 4
  • 收藏

The Year’s First Three IPOs All Struggled. This Is Why.

Barrons2022-01-08

The first initial public offerings of 2022, a trio of biotech companies, went public with dismal results.Amylyx Pharmaceuticals,and Vigil Neuroscience both dropped below their issue prices while ...

网页链接

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

举报

评论4

  • dahae
    ·2022-01-10
    Qqqq
    回复
    举报
    收起
    • dahae
      Qqqq
      2022-01-10
      回复
      举报
  • henghm
    ·2022-01-09
    Like and comments
    回复
    举报
    收起
  • Xxxtaengxx
    ·2022-01-08
    Ok
    回复
    举报
    收起
  • sh99
    ·2022-01-08
    why
    回复
    举报
    收起
    • Akyy12
      ok
      2022-01-08
      回复
      举报
    • Samwich
      Ok
      2022-01-08
      回复
      举报
    • sh99
      idk
      2022-01-08
      回复
      举报
 
 
 
 

热议股票

 
 
 
 
 

7x24